A prospective study of differences in duodenum compared to remaining small bowel motion between radiation treatments: Implications for radiation dose escalation in carcinoma of the pancreas
2006

Study on Small Bowel Motion During Pancreatic Radiation Therapy

Sample size: 9 publication Evidence: moderate

Author Information

Author(s): Anurag K Singh, Ryan M Tierney, Daniel A Low, Parag J Parikh, Robert J Myerson, Joseph O Deasy, Catherine S Wu, Gisele C Pereira, Sasha H Wahab, MS Sasa Mutic, Perry W Grigsby, Andrew J Hope

Primary Institution: National Cancer Institute, Bethesda, MD, USA

Hypothesis

Can we characterize the motion of the duodenum compared to the remaining small bowel during radiation treatments for pancreatic cancer?

Conclusion

The volume of small bowel irradiated during pancreatic radiation therapy changes significantly between fractions, suggesting that dose escalation may be possible.

Supporting Evidence

  • The volume of duodenum receiving at least 80% of the prescribed dose was consistently greater than the remaining small bowel.
  • In patients with the largest inter-fraction variation, the duodenum's irradiated volume ranged from 30% to 100%.
  • Only small volumes of non-duodenal small bowel received 80% of the prescribed dose.

Takeaway

This study looked at how much the small intestine moves during radiation therapy for pancreatic cancer, finding that the duodenum stays more stable than other parts.

Methodology

Nine patients undergoing radiation therapy had up to four weekly CT scans to analyze organ motion and dose distribution.

Limitations

Individual variations in organ motion make it difficult to establish general dose volume limits.

Participant Demographics

4 women and 5 men undergoing radiation therapy for pancreatic cancer.

Digital Object Identifier (DOI)

10.1186/1748-717X-1-33

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication